home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

5th Annual Formulation & Drug Delivery Congress

 
  November 20, 2018  
     
 
Oxford Global, London, United Kingdom
29 - 30 April 2019


Over 50 presentations and case studies focused on the key issues in large molecule and small molecule drug formulation and drug delivery

Including 5 interactive streams:

  • Large Molecule Drug Formulation
  • Advances in Drug Delivery
  • New to 2019! Continuous Manufacturing & Processing for Improved Efficiency 
  • Small Molecule Drug Formulation
  • Bioanalysis and Stabilisation

With New Featured Streams: 

  • New to 2019! Formulation & Delivery for RNA Therapies
  • New to 2019! Nanoparticle-medicated Formulation & Delivery 
 
 
Organized by: Oxford Global
Invited Speakers:

2019 Speakers Include:

Ekkehard Leberer, Senior Director, R&D Alliance Management
Sanofi

Shalini Andersson, Senior Director & Head of New Therapeutic Modalities
AstraZeneca

Pierre Souillac, Senior Director, Head of Formulation Development & Process Development
Shire

Vincent Ling, Senior Director, Materials & Innovation
Takeda 

Martinus Capelle, Scientific Director, Head of Formulation Science & Technology
Janssen Vaccines

Muthuraman Meiyappan, Director, Head of Analytical Research, Discovery Therapeutics
Shire

Theresa Scheuble, Director of Research & Development
Janssen

Preetanshu Pandey, Director
Kura Oncology

Jonas Fransson, Director
Swedish Orphan Biovitrum

Corinna Sonderegger, Head of Portfolio Management, Device Development & Commercialisation
Novartis

Ahmed Youssef, Head of Parenteral Unit/GMP Manufacturing
Sanofi

Sachin Dubey, Head of Formulation & Analytical Development
Glenmarck Pharmaceuticals

Jörg Schiewe, Head of CMC
Boehringer Ingelheim

Riccardo Torosantucci, Head of Formulation Development, Biologics
Sanofi

Aktham Aburub, Senior Research Advisor
Eli Lilly & Company

Tadashi Fujisawa, Chief Executive Officer
Mebiopharm

Alexander Scheer, Chief Scientific Officer
EryTech

Juho Jalkanen, Chief Development Officer
Faron Pharmaceuticals

Heinrich Haas, Vice President, RNA Formulation & Drug Delivery
BioNTech

Yogeshwar Bachhav, Associare Director, Pharmaceutical Development
AiCuris

Stefan Grudén, Director of Pharmaceutical R&D & Quality Assurance
Lidds Pharma

Jaymin Shah, Research Fellow & Pharmaceutical Sciences Team Leader
Pfizer

Ying Wang, Senior Principal Scientist, Group Leader
Pfizer

 

Please see rest of speakers here: https://bitly.com/

 
Deadline for Abstracts: N/A
 
Registration:

If you would like to receive further information on prices and discounts, please contact:

Guillaume Alonso
Marketing & CRM Manager
g.alonso@oxfordglobal.co.uk
+441865 248 455 

E-mail: g.alonso@oxfordglobal.co.uk
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.